Arenicin Polypeptide Treatment for Resistant UTI
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Increasing antimicrobial resistance in bacterial pathogens, particularly uropathogenic Escherichia coli strains, renders existing antibiotics ineffective in treating urinary tract infections, necessitating the development of novel antimicrobial agents.
Innovation Solution
The use of polypeptides with antimicrobial activity, specifically those having an amino acid sequence with at least 80% identity to a particular SEQ ID NO: 1, for treating urinary tract infections, including those caused by multiple drug-resistant E. coli strains, by exhibiting bactericidal and bacteriostatic effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat urinary tract infections, then treatment effectiveness is maintained against susceptible bacteria, but treatment fails against multiple drug-resistant E. coli strains
Solution Approach 1:
The patent changes the chemical parameter from conventional antibiotics to antimicrobial peptides with specific amino acid sequences (at least 80% identity to SEQ ID NO: 1), which have different mechanisms of action that bypass bacterial resistance to traditional antibiotics, thereby restoring treatment effectiveness against resistant strains
Solution Approach 2:
The invention uses polypeptides comprising multiple amino acid residues with specific properties (hydrophobic, hydrophilic, charged residues) arranged in a composite sequence structure that enables both membrane disruption and antimicrobial activity, creating a material that overcomes resistance to single-agent antibiotics
2Reliability
If new antimicrobial agents are developed to overcome resistance, then effectiveness against resistant strains is improved, but uncertainty about side effects and safety increases
Solution Approach 1:
The antimicrobial peptides exhibit local quality by being highly selective in their action - the specific amino acid sequence configuration (at least 80% identity to SEQ ID NO: 1) enables preferential interaction with bacterial membranes over mammalian cell membranes, achieving high effectiveness against resistant bacteria while minimizing harmful effects on host tissues
Solution Approach 2:
The peptides function as short-acting antimicrobial agents that achieve rapid bacterial killing (bactericidal effect) followed by rapid clearance, providing effective treatment without long-term accumulation that could lead to chronic side effects
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These polypeptides demonstrate significant bacterial reduction in urine, bladder, and kidneys, comparable to established antibiotics like Meropenem, effectively treating urinary tract infections while minimizing side effects.
Implementation Method 1
a polypeptide having antimicrobial activity, which comprises an amino acid sequence having at least 80% identity to the amino acid sequence of SEQ ID NO: 1
Implementation Method 2
exhibiting bactericidal and bacteriostatic effects
Implementation Method 3
exhibiting bactericidal and bacteriostatic effects
Data Source
AI summary
Provided is treatment of urinary tract infections including bladder infections caused by uropathogenic bacterial strains such as for example Escherichia coli with a beta-hairpin antimicrobial Arenicin polypeptide derived from the murine polychaeta Arenicola marina. Also provided are variants of Arenicin for treatment of urinary tract infections.